CervoMed Inc.
For the period ended Jun 8, 2026. Filed Apr 30, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 8, 2026 · Filed Apr 30, 2026
Use the contents to explore the available documents and sections.
Contents
Background
At our annual meeting of stockholders in June 2025, our stockholders approved the 2025 Equity Plan, replacing the 2015 Plan, which expired in 2025. The 2025 Equity Plan provides for the grant of incentive and non-statutory stock options, stock appreciation rights, restricted stock, RSUs, performance awards, stock bonuses and other stock-based awards. In the following discussion, we refer to both incentive stock options and non-statutory stock options as “options,” and to options, stock appreciation rights, restricted stock awards, RSUs, performance awards and stock bonuses as “incentive awards.”
The 2025 Equity Plan is currently our only active equity plan for issuing new equity compensation awards. Historically, we have granted equity-based awards primarily through our stockholder approved plan (our 2015 Equity Plan and 2025 Equity Plan) or, in certain cases, pursuant to inducement awards material to new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Grants under the 2018 Plan were primarily issued by EIP in periods prior to the Merger.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.